Trial Profile
Surveillance of Efficacy and Safety of Drug PRITOR in patieNts With Arterial Hypertension, Who do Not Tolerate ACE inhibitoR Treatment.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Apr 2010
Price :
$35
*
At a glance
- Drugs Telmisartan (Primary)
- Indications Hypertension
- Focus Adverse reactions; Therapeutic Use
- Acronyms SONAR
- Sponsors Bayer
- 21 Apr 2010 Planned number of patients changed from 2000 to 3114 as reported by ClinicalTrials.gov.
- 16 Dec 2009 Additional location (Romania) identified as reported by ClinicalTrials.gov.
- 16 Dec 2009 Planned number of patients changed from 2000 to 3114 as reported by ClinicalTrials.gov.